Here are six takeaways:
1. Dr. Thomas will succeed Wolf-Dietrich Hübner, MD, who is retiring.
2. A seasoned executive, Dr. Thomas has served as a medical practitioner for several organizations.
3. He has been actively involved in clinical research and product development.
4. In his new role, Dr. Thomas will head curasan’s medical affairs, clinical research, regulatory affairs and quality systems departments.
5. Dr. Thomas will serve on the company’s senior management team.
6. curasan develops, manufactures and makes bone and tissue regeneration products and biomaterials.
More articles on devices:
Zimmer Biomet jumps into value-based care with Signature Solutions: 5 things to know
5 key trends to watch for Mazor in the growing spinal robotics field
Open Payments data may need more nuance, S.C. physicians say — 5 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
